Previous reports suggested that PIR contributes to malignant transformation of cancer cells by acting as a transcriptional cofactor that interacts with the Bcl3–NF‐қB complex in several cancers (Adeniran and Hamelberg, 2017; Komai et al., 2015; Qiao et al., 2014). The gene discussed is BCL3; the disease is cancer.